초록접수 현황
| 14F-264 | 구연 발표 |
Thoracic Endovascular Aortic Repair for Acute Type B Aortic Dissection: Early and Midterm Results
허균, 임재웅, 최창우, 신화균
순천향대학교 의과대학 부천병원 흉부외과학교실
Background : Thoracic endovascular aortic repair(TEVAR) has replaced open surgical management for acute type B aortic dissection due to promising short- and midterm data. The purpose of this study was to examine our institutional experience with TEVAR for the treatment of acute type B aortic dissection.
Methods : Between June 2008 and June 2014, 28 consecutive patients underwent TEVAR for management of acute type B aortic dissection at a single referral institution. We reviewed the patient records retrospectively.
Results : The mean age was 61.5±14.3 (range 36-85) with 14 male patients. 3(11%) patients required one or more adjunctive procedures in addition to TEVAR to treat malperfusion syndrome. In-hospital mortality rates was 7.2% (n=2) and in-hospital rates of stroke, permanent paraplegia, and new-onset dialysis were 0% (n=0), 3.6% (n=1), and 7.2% (n=2), respectively. Median follow-up was 33.7 months [interquartile range, 4.4-32.3 months]. Overall survival at 1 and 2 years was 93% and 84%, respectively. There were 2(7.2%) patients in whom an endoleak was observed, but additional intervention was not required due to clinical nonsignificance.
Conclusion : This study confirms the excellent early and midterm outcomes of TEVAR for acute type B aortic dissection, but life-long aortic surveillance is important in order to identify and treat the aorta-related complications.
Methods : Between June 2008 and June 2014, 28 consecutive patients underwent TEVAR for management of acute type B aortic dissection at a single referral institution. We reviewed the patient records retrospectively.
Results : The mean age was 61.5±14.3 (range 36-85) with 14 male patients. 3(11%) patients required one or more adjunctive procedures in addition to TEVAR to treat malperfusion syndrome. In-hospital mortality rates was 7.2% (n=2) and in-hospital rates of stroke, permanent paraplegia, and new-onset dialysis were 0% (n=0), 3.6% (n=1), and 7.2% (n=2), respectively. Median follow-up was 33.7 months [interquartile range, 4.4-32.3 months]. Overall survival at 1 and 2 years was 93% and 84%, respectively. There were 2(7.2%) patients in whom an endoleak was observed, but additional intervention was not required due to clinical nonsignificance.
Conclusion : This study confirms the excellent early and midterm outcomes of TEVAR for acute type B aortic dissection, but life-long aortic surveillance is important in order to identify and treat the aorta-related complications.
책임저자: 허균
순천향대학교 의과대학 부천병원 흉부외과학교실
연락처 : 허균, Tel: 032-621-5068 , E-mail : besurgeon@hanmail.net
